Bin Ma
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 07, 2026
Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation.Brian T Hopkins, Isaac E Marx, Harlod George Vandeveer
|May 07, 2024
Discovery and Preclinical Characterization of BIIB129, a Covalent, Selective, and Brain-Penetrant BTK Inhibitor for the Treatment of Multiple Sclerosis.Martin K Himmelbauer, Bekim Bajrami, Rebecca Basile
|Aug 16, 2023
Discovery of Potent Allosteric DRP1 Inhibitors by Disrupting Protein-Protein Interaction with MiD49.Takeru Furuya, Jean Lin, Arina Afanaseva
|Nov 04, 2021
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis.Brian T Hopkins, Eris Bame, Bekim Bajrami
|Jul 16, 2021
Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546.Bin Ma, Lei Zhang, Lihong Sun
|Jul 23, 2020
Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases.Bin Ma, Tonika Bohnert, Kevin L Otipoby
Pageof 1
